NEWS
Our Latest News
ARCHIMED’s MED II sells DIESSE, returning 4.6x to shareholders
ARCHIMED’s MED II sells DIESSE, returning 4.6x to shareholders
Private equity healthcare specialist ARCHIMED announces the sale of DIESSE to private equity firm Fremman Capital. The transaction caps a five-year partnership with DIESSE and marks the latter’s transformation into a leading clinical diagnostics innovator. The deal returns 4.6 times invested capital to shareholders.
ARCHIMED acquires Deallus Consulting
November
9,
2015
ARCHIMED acquires stakes in RehabWorks and Primo
November
9,
2015
ARCHIMED has acquired control of MediStream
September
9,
2014
368